Brief: Flerie's Bonsai Biotherapeutics Gets Clinical Trial Application Approval
26/06/2026 09:03
BRIEF-Flerie's Bonsai Biotherapeutics Gets Clinical Trial Application Approval June 26 (Reuters) - Flerie AB FLERIE.ST:
PORTFOLIO COMPANY BONSAI BIOTHERAPEUTICS RECEIVES FULL APPROVAL OF CLINICAL TRIAL APPLICATION FOR TOL2 IN MYASTHENIA GRAVIS
Source text: ID:nMFN4KQfNl
Further company coverage: FLERIE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen